Kilitch Drugs (India) Ltd Share Price
(KILITCH)
₹345.35
as on 04:01PM, 25 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.66 % |
3 Month Return | + 7.87 % |
1 Year Return | -3.87 % |
Market Stats | |
Previous Close | ₹354.70 |
Open | ₹359.95 |
Volume | 7,232.00 |
Upper Circuit | ₹425.60 |
Lower Circuit | ₹283.80 |
Market Cap | ₹555.40Cr |
P/E Ratio
28.45
PEG Ratio
9.74
Market Cap
₹555.40 Cr
P/B Ratio
2.81
EPS
8.44
Dividend Yield
0Sector
Pharmaceuticals
ROE
8.39
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, KILITCH stock has moved up by 10.8%
Revenue Rich
Revenue is up for the last 3 quarters, 36.03 Cr → 57.89 Cr (in ₹), with an average increase of 20.3% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.23% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.7% return, outperforming this stock by 59.7%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 143.4% return, outperforming this stock by 60.7%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 30.77% of holdings in Mar 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 8.62 Cr → 5.96 Cr (in ₹), with an average decrease of 30.9% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 69.23% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 30.77% | 0.00 | |
Others | 0% | 0.00 |
Kilitch Drugs (India) Ltd in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (28.45x)
April 25, 2025
Industry (55.10x)
April 25, 2025
Highest (363.79x)
October 16, 2020
Kilitch Drugs (India) Ltd’s net profit jumped 104.81% since last year same period to ₹5.96Cr in the Q3 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -30.86% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.14%.
Read More about DividendsBearish
Neutral
Bullish
Kilitch Drugs (India) Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹555.40 Cr | 45.07% | 0.56 | ₹13 Cr | ₹154 Cr | |
NA | ₹190.20 Cr | 59.02% | 0.62 | NA | NA | |
NA | ₹309.72 Cr | 50.21% | 0.78 | NA | NA | |
NA | ₹779.36 Cr | 409.2% | 0.65 | ₹23 Cr | ₹307 Cr | |
NA | ₹67.48 Cr | -1.55% | 0.57 | NA | NA |
Organisation | Kilitch Drugs (India) Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Kilitch Drugs (India) Ltd share price today stands at ₹345.35, Open: ₹359.95, Previous Close: ₹354.7, High: ₹369.95, Low: ₹340, 52 Week High: ₹404.95, 52 Week Low: ₹299.95.
Today's traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 7,232.00.
Today's market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹555.4Cr.
Kilitch Drugs (India) Ltd (KILITCH) share price is ₹345.35. It is down -14.72% from its 52 Week High price of ₹404.95
Kilitch Drugs (India) Ltd (KILITCH) share price is ₹345.35. It is up 15.14% from its 52 Week Low price of ₹299.95